Journals
RSS Feed Readers

Filter by Tag:   Date:
Journals
10
Aug

Glenmark’s Revamilast Goes into Phase IIb Clinical Trial

Posted by: Admin

Glenmark Initiates Global Phase II Clinical trial for its Novel Chemical Entity for Rheumatoid Arthritis and Asthma Revamilast is a Novel Chemical Entity...Read More

02
Aug

Add-On Leflunomide in Rheumatoid Arthritis Increase Risk of Hepatotoxicity

Posted by: Admin

Disease-Modifying Antirheumatic Drugs, Leflunomide Increase Risk of Hepatotoxicity Research report, “Risk of hepatotoxicity with add-on leflunomide...Read More

09
Jun

A Novel Drug for Rheumatoid Arthritis Is On The Anvil

Posted by: Admin

A Novel Orally Active Janus kinase (JAK) inhibitor, GLPG0634 in Phase II trial   A mid-sized pharmaceutical company is developing a novel orally...Read More

Journals are primarily meant for Medical practitioners and healthcare service providers to find out what’s new and happening in the medical world. Latest scientific breakthroughs, research, events and conferences will all be there for you. This section of HealthLine 24x7 will ensure that you are constantly updated on the latest discovery, innovation and experiment. You can browse through the journal content available on HealthLine 24x7 either date wise or category wise. The current categories available are Cardiology, Neurology and Oncology. The few journals available on Healthline24x7 currently are, “Alzheimer and Heart Disease Share a Common Gene according To the Latest Research,” “A Ray of Hope for Patients with Severe Aortic Stenosis,” “Vioxx and Heart Attack-The Mystery Solved,” “Repairing Damaged Hearts, Naturally,” “To Get A Mammogram Or Not.”